Compounds > risperidone

Page last updated: 2024-08-16

risperidone and oxybutynin

risperidone has been researched along with oxybutynin in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (30.00)	29.6817
2010's	6 (60.00)	24.3611
2020's	1 (10.00)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM	1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ	1
Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Hughes, DA	1
Aggarwal, G; Dhawan, S; Hari Kumar, SL	1
Fang, L; Liu, C; Quan, P; Weng, W; Zhao, H	1
Adwan, S; Al-Akayleh, F; Al-Remawi, M; Idkaidek, N; Khanfar, M	1

Reviews

1 review(s) available for risperidone and oxybutynin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

9 other study(ies) available for risperidone and oxybutynin

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19 Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship	2008
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics	2010
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment. Journal of applied toxicology : JAT, 2012, Volume: 32, Issue:10 Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers	2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Estimation of the impact of noncompliance on pharmacokinetics: an analysis of the influence of dosing regimens. British journal of clinical pharmacology, 2008, Volume: 65, Issue:6 Topics: Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Mandelic Acids; Models, Biological; Parasympatholytics; Patient Compliance; Risperidone; Statistics as Topic; Time Factors	2008
Formulation, in vitro and in vivo evaluation of transdermal patches containing risperidone. Drug development and industrial pharmacy, 2013, Volume: 39, Issue:1 Topics: Animals; Antipsychotic Agents; Biological Availability; Female; Male; Mice; Olea; Peanut Oil; Permeability; Plant Oils; Polymethacrylic Acids; Rabbits; Rats; Rats, Wistar; Risperidone; Skin; Transdermal Patch; Waxes	2013
Design of a Drug-in-Adhesive Transdermal Patch for Risperidone: Effect of Drug-Additive Interactions on the Crystallization Inhibition and In Vitro/In Vivo Correlation Study. Journal of pharmaceutical sciences, 2016, Volume: 105, Issue:10 Topics: Animals; Crystallization; Drug Design; Drug Interactions; Magnetic Resonance Spectroscopy; Male; Organ Culture Techniques; Rabbits; Risperidone; Skin Absorption; Spectroscopy, Fourier Transform Infrared; Transdermal Patch	2016
A Novel Eutectic-Based Transdermal Delivery System for Risperidone. AAPS PharmSciTech, 2020, Nov-22, Volume: 22, Issue:1 Topics: Administration, Cutaneous; Animals; Antipsychotic Agents; Biological Availability; Rats; Risperidone; Solubility; Solvents; Temperature; Transdermal Patch; Viscosity	2020